Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-05-13 Sale | 2024-05-15 5:20 pm | Evolus Inc. | EOLS | GILL DAVID N Director | 10,361 | $12.64 | $131,010 | 33,964 (Direct) | View |
| 2022-05-13 Sale | 2022-05-17 6:49 pm | Evolus Inc. | EOLS | GILL DAVID N Director | 10,313 | $13.35 | $137,664 | 29,568 (Direct) | View |
| 2021-01-19 Sale | 2021-01-20 4:16 pm | Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director | 2,000 | $46.52 | $93,045 | 24,000 (Direct) | View |
| 2020-11-18 Sale | 2020-11-20 4:15 pm | Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director | 2,000 | $45.77 | $91,530 | 26,000 (Direct) | View |
| 2020-11-03 Sale | 2020-11-05 5:51 pm | Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director | 4,000 | $45 | $180,000 | 28,000 (Direct) | View |
| 2020-09-24 Purchase | 2020-09-28 07:48 am | Strongbridge Biopharma plc | SBBP | GILL DAVID N Director | 8,000 | $2.13 | $17,040 | 74,896 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-11 Option Award | 2024-06-13 9:00 pm | N/A 2034-06-11 | Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director | 18,040 | $0 | 20,370 (Direct) | View |
| 2024-02-07 Option Award | 2024-02-09 6:37 pm | N/A 2034-02-07 | Evolus Inc. | EOLS | GILL DAVID N Director | 15,841 | $0 | 53,702 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-09 6:01 pm | N/A 2033-06-08 | Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director | 16,280 | $0 | 16,280 (Direct) | View |
| 2023-01-27 Option Award | 2023-01-31 8:41 pm | N/A 2033-01-27 | Evolus Inc. | EOLS | GILL DAVID N Director | 20,082 | $0 | 49,650 (Direct) | View |
| 2022-07-15 Option Award | 2022-07-19 1:20 pm | N/A 2032-07-14 | Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2022-01-24 Option Award | 2022-01-26 9:01 pm | N/A 2032-01-24 | Evolus Inc. | EOLS | GILL DAVID N Director | 38,295 | $0 | 62,608 (Direct) | View |
| 2021-10-05 Disposition | 2021-10-06 7:41 pm | N/A N/A | Strongbridge Biopharma plc | SBBP | GILL DAVID N Director | 78,058 | $0 | 0 (Direct) | View |
| 2021-10-01 Tax Withholding | 2021-10-05 7:21 pm | N/A N/A | Strongbridge Biopharma plc | SBBP | GILL DAVID N Director | 17,763 | $2.06 | 78,058 (Direct) | View |
| 2021-06-10 Option Award | 2021-06-14 5:03 pm | 2021-07-10 2031-06-10 | Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2021-05-18 Option Award | 2021-05-18 7:10 pm | N/A N/A | Strongbridge Biopharma plc | SBBP | GILL DAVID N Director | 40,000 | $0 | 95,821 (Direct) | View |
| 2021-05-14 Tax Withholding | 2021-05-17 6:29 pm | N/A N/A | Strongbridge Biopharma plc | SBBP | GILL DAVID N Director | 19,075 | $2.35 | 55,821 (Direct) | View |
| 2021-02-05 Option Award | 2021-02-09 5:13 pm | N/A N/A | Evolus Inc. | EOLS | GILL DAVID N Director | 19,313 | $0 | 24,313 (Direct) | View |
| 2021-01-19 Exercise | 2021-01-20 4:16 pm | N/A N/A | Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director | 2,000 | $11.16 | 24,000 (Direct) | View |
| 2021-01-19 Exercise | 2021-01-20 4:16 pm | N/A 2028-04-24 | Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director | 2,000 | $0 | 24,000 (Direct) | View |
| 2020-11-18 Exercise | 2020-11-20 4:15 pm | N/A N/A | Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director | 2,000 | $11.16 | 26,000 (Direct) | View |
| 2020-11-18 Exercise | 2020-11-20 4:15 pm | N/A 2028-04-24 | Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director | 2,000 | $0 | 26,000 (Direct) | View |
| 2020-11-03 Exercise | 2020-11-05 5:51 pm | N/A N/A | Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director | 4,000 | $11.16 | 28,000 (Direct) | View |
| 2020-11-03 Exercise | 2020-11-05 5:51 pm | N/A 2028-04-24 | Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director | 4,000 | $0 | 28,000 (Direct) | View |
| 2020-09-03 Tax Withholding | 2020-09-04 4:28 pm | N/A N/A | Strongbridge Biopharma plc | SBBP | GILL DAVID N Director | 23,104 | $3.61 | 66,896 (Direct) | View |
| 2020-06-23 Option Award | 2020-06-24 4:46 pm | 2020-07-23 2030-06-23 | Y-mAbs Therapeutics Inc. | YMAB | GILL DAVID N Director | 16,000 | $0 | 16,000 (Direct) | View |
| 2020-05-14 Option Award | 2020-05-15 4:47 pm | N/A N/A | Strongbridge Biopharma plc | SBBP | GILL DAVID N Director | 40,000 | $0 | 90,000 (Direct) | View |
| 2020-01-23 Option Award | 2020-01-24 9:07 pm | N/A 2030-01-23 | Evolus Inc. | EOLS | GILL DAVID N Director | 23,458 | $0 | 23,458 (Direct) | View |
| 2019-11-22 Option Award | 2019-11-26 4:33 pm | N/A N/A | STRATA Skin Sciences Inc. | SSKN | GILL DAVID N Director | 18,293 | $0 | 64,694 (Direct) | View |